ArticleGastroenterology research2022

Gastrointestinal Toxicities of Immune Checkpoint Inhibitors Are Associated With Enhanced Tumor Responsiveness and Improved Survival.

Mohammad Alomari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.